Literature DB >> 27376115

Treatment Decision Making in Patients with Bladder Cancer.

Donna L Berry1, Manan Nayak1, Barbara Halpenny1, Shannon Harrington1, Kevin R Loughlin2, Peter Chang3, Jonathan E Rosenberg4, Adam S Kibel2.   

Abstract

Background: Each stage of bladder cancer involves varying treatment issues and concerns that are discussed between patients and providers during the pre-treatment consultation. There is no documentation of how patients engage in decision making. Objective: To describe aspects of treatment decision making perceived by patients with bladder cancer using qualitative analysis of data from individual interviews.
Methods: Patients with any stage bladder cancer were recruited from urology and medical oncology services at a comprehensive cancer center. A qualitative approach to data collection and analysis was applied. Individual, semi-structured interviews were conducted, recorded and transcribed. Coding of the transcripts was conducted by research team members, discussed for consensus and major themes derived.
Results: 45 men and 15 women, the majority college educated, were recruited. Where to receive care, including from whom, was the initial and major decision. Challenges of decisions regarding urinary reconstruction were dominant. Personal characteristics, including age and being active, were considered. Participants with early stage tumors (n = 28) typically perceived only one treatment option and followed the physician's recommendation. The 18 participants with stage II-III were aware of multiple options. In 14 stage IV participants, balancing quality of life and outcomes between treatments was common to the decision process. Conclusions: For this educated sample with bladder cancer, recruited at a comprehensive cancer center, the major decision was to seek treatment at a location with the highest level of physician expertise. Personal preferences informed decisions surrounding bladder reconstruction. Further research will be conducted in a diverse sample of patients making decisions in a non-urban, community setting.

Entities:  

Keywords:  Bladder cancer; qualitative evaluation; shared decision making

Year:  2015        PMID: 27376115      PMCID: PMC4927892          DOI: 10.3233/BLC-150029

Source DB:  PubMed          Journal:  Bladder Cancer


  22 in total

1.  Knowledge and prevention practices before breast cancer diagnosis in a cross-sectional study among survivors: impact on patients' involvement in the decision making process.

Authors:  Emanuela Taioli; Gail R Joseph; Linda Robertson; Stacy Eckstein; Camille Ragin
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

2.  Grounded theory, mixed methods, and action research.

Authors:  Lorelei Lingard; Mathieu Albert; Wendy Levinson
Journal:  BMJ       Date:  2008-08-07

3.  Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.

Authors:  Shoshana M Rosenberg; Karen Sepucha; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Meghan E Meyer; Lidia Schapira; Steven E Come; Virginia F Borges; Mehra Golshan; Eric P Winer; Ann H Partridge
Journal:  Ann Surg Oncol       Date:  2015-05-01       Impact factor: 5.344

Review 4.  Sampling in qualitative research. Purposeful and theoretical sampling; merging or clear boundaries?

Authors:  I T Coyne
Journal:  J Adv Nurs       Date:  1997-09       Impact factor: 3.187

Review 5.  Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.

Authors:  Kirk A Keegan; Harras B Zaid; Sanjay G Patel; Sam S Chang
Journal:  Curr Urol Rep       Date:  2014-04       Impact factor: 3.092

Review 6.  A systematic review of factors influencing older adults' decision to accept or decline cancer treatment.

Authors:  Martine T E Puts; Brianne Tapscott; Margaret Fitch; Doris Howell; Johanne Monette; Doreen Wan-Chow-Wah; Monika Krzyzanowska; Nathasha B Leighl; Elena Springall; Shabbir M Alibhai
Journal:  Cancer Treat Rev       Date:  2014-12-26       Impact factor: 12.111

7.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

8.  Treatment decision-making by men with localized prostate cancer: the influence of personal factors.

Authors:  Donna L Berry; William J Ellis; Nancy Fugate Woods; Christina Schwien; Kristin H Mullen; Claire Yang
Journal:  Urol Oncol       Date:  2003 Mar-Apr       Impact factor: 3.498

9.  Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer.

Authors:  Aileen B Chen; Angel Cronin; Jane C Weeks; Elizabeth A Chrischilles; Jennifer Malin; James A Hayman; Deborah Schrag
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

10.  Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results.

Authors:  Jeff Nix; Angela Smith; Raj Kurpad; Matthew E Nielsen; Eric M Wallen; Raj S Pruthi
Journal:  Eur Urol       Date:  2009-10-20       Impact factor: 20.096

View more
  9 in total

1.  Involving Patients in the Development and Evaluation of an Educational and Training Experiential Intervention (ETEI) to Improve Muscle Invasive Bladder Cancer Treatment Decision-making and Post-operative Self-care: a Mixed Methods Approach.

Authors:  Nihal Mohamed; Tung Ming Leung; Qainat N Shah; Sailaja Pisipati; Donna L Berry; Emma K T Benn; Cheryl T Lee; Simon Hall; Reza Mehrazin; John Sfakianos
Journal:  J Cancer Educ       Date:  2020-08       Impact factor: 2.037

2.  Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer.

Authors:  Matthew D Galsky; Michael Diefenbach; Nihal Mohamed; Charles Baker; Sumit Pokhriya; Jason Rogers; Ashish Atreja; Liangyuan Hu; Che-Kai Tsao; John Sfakianos; Reza Mehrazin; Nikhil Waingankar; William K Oh; Madhu Mazumdar; Bart S Ferket
Journal:  JCO Clin Cancer Inform       Date:  2017-11

Review 3.  Understanding health decision making: An exploration of homophily.

Authors:  Donna L Berry; Traci M Blonquist; Rachel Pozzar; Manan M Nayak
Journal:  Soc Sci Med       Date:  2018-08-24       Impact factor: 4.634

Review 4.  From fast-track to enhanced recovery after surgery in radical cystectomy pathways: A nursing perspective.

Authors:  Bente Thoft Jensen; Nora Love Retinger; Susanne Vahr Lauridsen
Journal:  Asia Pac J Oncol Nurs       Date:  2022-03-12

5.  Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer.

Authors:  Tullika Garg; Jill Nault Connors; Ilene G Ladd; Tyler L Bogaczyk; Sharon L Larson
Journal:  Bladder Cancer       Date:  2018-01-20

Review 6.  The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.

Authors:  Amanda J Edmondson; Jacqueline C Birtwistle; James W F Catto; Maureen Twiddy
Journal:  J Cancer Surviv       Date:  2017-02-17       Impact factor: 4.442

7.  Recovering from Cystectomy: Patient Perspectives.

Authors:  Carmit K McMullen; Marilyn L Kwan; Janice C Colwell; Julie R Munneke; James V Davis; Alison Firemark; Neon Brooks; Marcia Grant; Scott M Gilbert; Andrea Altschuler
Journal:  Bladder Cancer       Date:  2019-01-31

8.  Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.

Authors:  Jiil Chung; Girish S Kulkarni; Robin Morash; Andrew Matthew; Janet Papadakos; Rodney H Breau; David Guttman; Jackie Bender; Jennifer M Jones
Journal:  Support Care Cancer       Date:  2019-02-14       Impact factor: 3.603

9.  Quality of life versus length of life considerations in cancer patients: A systematic literature review.

Authors:  Anne Shrestha; Charlene Martin; Maria Burton; Stephen Walters; Karen Collins; Lynda Wyld
Journal:  Psychooncology       Date:  2019-05-15       Impact factor: 3.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.